Your browser doesn't support javascript.
loading
Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice.
Yang, Yang; Mouri, Akihiro; Lu, Qiaohui; Kunisawa, Kazuo; Kubota, Hisayoshi; Hasegawa, Masaya; Hirakawa, Mami; Mori, Yuko; Libo, Zou; Saito, Kuniaki; Nabeshima, Toshitaka.
Afiliación
  • Yang Y; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Mouri A; Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
  • Lu Q; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan. mouri@fujita-hu.ac.jp.
  • Kunisawa K; Japanese Drug Organization of Appropriate Use and Research, Toyoake, Aichi, 468-0069, Japan. mouri@fujita-hu.ac.jp.
  • Kubota H; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Hasegawa M; Department of Pharmacology, Life Science and Biopharmaceutics School, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
  • Hirakawa M; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Mori Y; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Libo Z; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Saito K; Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
  • Nabeshima T; Department of Advanced Diagnostic System Development, Fujita Health University, Graduate School of Health Sciences, Toyoake, Aichi, 470-1192, Japan.
Neurochem Res ; 47(9): 2865-2879, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35871433
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Saponinas / Triterpenos / Trastorno Depresivo Mayor Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Neurochem Res Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Saponinas / Triterpenos / Trastorno Depresivo Mayor Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Neurochem Res Año: 2022 Tipo del documento: Article País de afiliación: Japón